Problems in the Assessment of Tumor Size: An Elusive Grail in Current Practice

Seminars in Breast Disease

Volumn 8, Issue 1, 2005, Pages 24-30

  Lagios, Michael D ^a  

^a Breast Cancer Consultation Service   (United States)

Author keywords

adjuvant therapy; breast pathology; image detected breast carcinoma; pathology practice; tumor size

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; MEDICAL PRACTICE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; RADIODIAGNOSIS; RELIABILITY; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; TUMOR VOLUME;

EID: 33746261329     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sembd.2006.03.009     Document Type: Article

References (20)

1. Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 (2004) 2817-2826
2. Tabar L., Duffy S.W., Vitak B., et al. The natural history of breast carcinoma. what have we learned from screening?. Cancer 86 (1999) 449-462
3. Elkin E.B., Hudis C., Begg C.B., et al. The effect of changes in tumor size on breast cancer survival in the U.S. 1975-1999. Cancer 104 (2005) 1149-1157
4. Joensuu H., Lehtimaki T., Holli K., et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 292 (2004) 1064-1073
5. Shen Y., Yand Y., Inove L.Y.T., et al. Role of detection method in predicting breast cancer survival. analysis of randomized screening trials. J Natl Cancer Inst 97 (2005) 1195-1203
6. Silverstein M.J. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology 17 (2003) 1511-1533
7. Fisher B., Costantio J., Redmond C., et al. Tamoxifen and chemotherapy for lymph node-negative estrogen receptor-positive breast cancer. J Natl Cancer Inst 89 (1997) 1673-1682
8. Singletary S.E., Allred C., Ashley P., et al. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 20 (2002) 3628-3636
9. International Breast Cancer Consensus Conference. Image-detected breast cancer. state of the art diagnosis and treatment. J Am Coll Surg 193 (2001) 297-302
10. Silverstein M.J., Lagios M.D., Recht A., et al. Image-detected breast cancer. state of the art diagnosis and treatment. J Am Coll Surg 201 (2005) 586-597
11. Lagios M.D. Duct carcinoma in situ. pathology and treatment. Surg Clin North Am 70 (1990) 853-871
12. Lagios M.D., Westdahl P.R., Margolin F.R., et al. Ductal carcinoma in situ. relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50 (1982) 2309-1314
13. Lagios M.D., Margolin F.R., Westdahl P.R., et al. Mammographically detected duct carcinoma in situ. frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63 (1989) 618-624
14. Silverstein M.J., Lagios M.D., Craig P.H., et al. A prognostic index for ductal carcinoma of the breast in situ. Cancer 77 (1996) 2267-2274
15. Silverstein M.J., Lagios M.D., Groshen S., et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340 (1999) 1455-1461
16. Fisher B., Constantino J., Redmond C., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328 (1993) 1581-1586
17. Fisher E.R., Constantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Cancer 75 (1995) 1310-1319
18. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ. an update of the National Surgical Breast and Bowel Project experience. Sem Oncol 28 (2001) 400-418
19. Julien J.P., Bijker N., and Fentiman I.S. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ. first results of the EORTC randomized Phase III trail 10853. Lancet 355 (2000) 528-533
20. Bijker N., Peterse J.L., Fentiman I.S., et al. Effects of patient selection on the applicability of results from a randomized clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS. Br J Cancer 87 (2002) 615-620